A profile of synthetic biology research and innovation is presented using data on publications and patents worldwide and for the UK and selected benchmark countries. The search approach used to identify synthetic biology publications identifies a core set of synthetic biology papers, extracts and refines keywords from these core records, searches for additional papers using those keywords, and supplements with articles published in dedicated synthetic biology journals and curated synthetic biology special collections. For the period from 2000 through to mid-July 2018, 11,369 synthetic biology publication records are identified worldwide. For patents, the search approach uses the same keywords as for publications then identifies further patents using a citation-tree search algorithm. The search covered patents by priority year from 2003 to early August 2018. Following geographical matching, 8,460 synthetic biology basic patent records were identified worldwide. Using this data, analyses of publications are presented which look at the growth of synthetic biology outputs, top countries and leading organizations, international co-authoring, leading subject categories, citations, synthetic biology on the map of science, and funding sponsorship. For patents, the analysis examines growth in patenting, national variations in publications compared with patenting, leading patent assignees, and the positioning of synthetic biology on a visualized map of patents. 3
Overview of Methods and Sources
In this paper, we provide an overview profile of synthetic biology research and innovation using data on publications and patents worldwide and for the UK and selected benchmark countries.
The data source for publications is the Web of Science (WOS). This is a leading large-scale database of bibliometric and citation records. 1 The search approach used to identify synthetic biology publications within the WoS follows the procedures described in Shapira et al. (2017) . 2 The approach identifies a core set of synthetic biology papers, extracts and refines keywords from these core records, searches for additional papers using those keywords, and supplements with articles published in dedicated synthetic biology journals and curated synthetic biology special collections. The search covers synthetic biology publications recorded in WoS from 2000 through to mid-July 2018. 3 VantagePoint textmining software is used to clean and analyze the publication records. 4 Records were de-duplicated using the WOS ISI Unique Article Identifier. In total, the combined and cleaned data set comprises 11,369 synthetic biology publication records.
For patents, the main data source is Derwent Innovations, which offers a recognized and curated global database of patents and patent applications. 5 The search approach used to identify synthetic biology patents follows Kwon et al. (2016) . 6 The approach employed the same keywords as for publications (see Shapira et al., 2017) to identify an initial set of patent records. Further patents were identified using a citation-tree search algorithm. The search covered patents by priority year from 2003 to 2018 (as of Aug 3, 2018), with 9,263 Derwent Innovations patent records identified. Geographical address information for assignees was obtained by record matching with PATSTAT. 7 This identified 8,498 matching patent records (including 8,460 records with basic patent numbers for the original invention in a patent family).
As an emerging, dynamic, multidisciplinary domain, there are multiple complexities in defining synthetic biology, as well as constraints in the available data sources. For detailed discussions of these issues, the search methods adopted, and their strengths and limitations when applied to identifying synthetic biology publications and patents, reference should be made to the Shapira et al. (2017) and Kwon et al. (2016) respectively.
The following sections present key results from our analyses of synthetic biology publication and patents.
Synthetic Biology Publications
Global Growth of Synthetic Biology Publications Synthetic biology publications as identified in the WoS increased, on an annualized basis, from under 200 publications worldwide in the early 2000s to over 500 in 2010. We estimate that worldwide publications will reach about 1450 in 2018. The four leading countries, by authorship, in producing synthetic biology publications are the USA, the UK, China, and Germany. (Figure 1. ) Authors from these four countries account for more than 70 per cent of all synthetic biology publications from 2000 through to the present (Table 1) . Table 1 shows the top 15 countries for synthetic biology publications for the 2000-2017 period, based on author countries. The USA is the leading country, producing more than two-fifths of the world's synthetic biology publications, although its share of the world total has dipped across the three periods depicted in the 2000-2006 2007-2012 2012-2017 2000-2017 2000-2006 2007-2012 2012-2017 2000-2017 
International Co-authoring in Synthetic Biology
Co-authorship is the norm in synthetic biology, as in most other areas of science. Of the 11,368 synthetic biology publications in our 2000-2018* (*part year) WoS dataset, only 10% have a single author. Over one-third (34.1%) of the publications have 2-3 authors, while more than another third (35.4%) have 4-6 authors. Another 15.6% have 7-10 authors.
Co-authorship can occur among researchers in the same institution, in the same country, and across international boundaries. There are variations in the propensity of countries for international coauthorship. For example, among the four leading producers of synthetic biology publications (by publication counts), just over one quarter of US publications are internationally co-authored, with authors from China, the UK, and Canada being the three most prevalent. For the UK, 43% of synthetic biology publications are internationally-co-authored, most noticeably with the US (about 15% of all UK synthetic biology publications), followed by Germany and France. For the UK, 21% (271, non-duplicated) of its synthetic biology publications (2000-2018 part year) are with researchers from other member states of the European Union (EU). The four largest EU co-authoring partners for the UK are Germany (6.0%), France (4.3%), Italy (3.9%) and the Netherlands (3.3%). Germany also has a high international co-authorship rate (46% of all its synthetic biology publications), with the US, the UK, and Switzerland as the leading three international co-authors for German researchers. In China, international co-authorships comprise just over one-third of its synthetic biology publications, with the US contributing to nearly one fifth of Chinese publications in the domain. The UK is the second most common international co-authorship partner for Chinese researchers. (Table 3 .) 8 (Authors from multiple countries may contribute to some of these publications; hence totaling international co-authorships for each country with a subject country will exceed the total of subject country non-duplicated co-authorships).
A global mapping, for the top 15 countries by synthetic biology publications, demonstrates the dominant role of the US in synthetic biology international co-authorship linkages ( Figure 3 ). The US leads as a synthetic biology co-authorship partner for the other top countries. The UK, China and Germany also serve as next tier hubs in international synthetic biology co-authorships. In addition to the dominant US network, there is also a European network (including the UK, Germany, France, Switzerland, Spain and Italy) and a Chinese network (involving the UK, US, Japan, Germany, and Australia among other countries). 
UK Co-Authoring in Synthetic Biology
Mapping co-authorship linkages of synthetic biology publications demonstrates the hub roles of the four leading locations by publication counts: Imperial College, the University of Edinburgh, the University of Oxford, and the University of Manchester. The University of Cambridge, Bristol University, the University of Warwick, and University College London also are among those with noticeable hub roles. (Figure 4 .) 
Leading Subject Categories Addressed by Synthetic Biology
The Web of Science allocates every journal, book or other publication that it records to at least one subject category. Currently, there are more than 250 WoS subject categories. 9 These subject categories broadly relate to disciplines, although there are also some general and interdisciplinary categories. Synthetic biology is a crosscutting domain that covers multiple disciplines of science and technology and, indeed, seeks to engage and recombine key disciplines such as biology and biotechnology, engineering, and computing. Overall, our analysis indicates that synthetic biology publications encompass 188 or about three-quarters of WoS subject categories (Table 4 ). To visualize the subject distributions and interdisciplinary linkages between subjects, we overlay our synthetic biology publication dataset onto a base map of science. 10 Our dataset covers synthetic biology publications in the WoS from 2000 through to mid-July 2018. While the visualization for all publications worldwide shows a spread of synthetic biology publications across disciplines, there are larger macro clusters in "Biochemistry, Molecular and Cell Biology," "Biotechnology" (including plant sciences), and "Chemistry" (including biochemical research methods and chemistry, multidisciplinary). UK synthetic biology publications on the map of science are broadly comparable, with relatively more prominent clustering in multidisciplinary sciences and relatively greater linkages with computer science and engineering. (Figure 5 Science and Technology, 61(9) , 1871-1897, doi: 10.1002/asi.21368. As noted in Shapira et al, 2017, "the map visualizes the distance and intensity of co-citations between corresponding subject categories. Each node represents individual WoS subject categories, with colors used to depict subject categories within the same macro-discipline group. The subject categories that are assigned to synthetic biology articles in our publication dataset are matched to the 18 macro-disciplines and displayed on the base map" and "the node size is proportional to the number of articles in that subject category." For the method to construct the 18 macro disciplines, see Carley, S., Porter, A. L., Rafols, I., & Leydesdorff, L. (2017) . Visualization of disciplinary profiles: Enhanced science overlay maps. Journal of Data and Information Science, 2(3) , 68-111, https://content.sciendo.com/view/journals/jdis/2/3/article-p68.xml. The VOSviewer clustering method and algorithm is used, see: van Eck, N. J., & Waltman, L. (2010). Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics, 84(2), 523-538. doi: 10.1007/s11192-009-0146-3. 
Citations to Synthetic Biology Publications
Using citations to scientific publications as measures of research quality and impact is an imperfect but nonetheless commonly used indicator. 11 Bearing in mind the limitations of using citation measures, we do observe significant differences among the top synthetic biology publishing countries in mean citations to papers attributed to one or more authors affiliated with institutions in those countries. Two North American countries -Canada and the USboth average more than 30 citations per publication in synthetic biology (noting that the US produces 10 times more publications than Canada). Switzerland averages almost 24 citations per publication, with Germany, the UK, and Netherlands each averaging around 20 citations per publication. Although third-ranked by publication count, China has the lowest mean citation rate among the top 15 synthetic biology countries. (Figure 6 .) 
Funding Sponsorship
The top 15 funding organizations, by publication counts, in synthetic biology account for about 42% of all records in the synthetic biology publications data set. 12 Among these top 15 funding organizations, six are in North America (with five in the US), five are in Europe (including two in the UK), and four are located in Asia (with two in China and Japan respectively). (Figure 7 .) A publication may acknowledge funding from more than one sponsor, with some papers sponsored by funders in different countries. The highest mean citations per publication are garnered by publications that acknowledge funding from the US Office of Naval Research, followed by the US National Institutes of Health (NIH), the US Defense Advanced Research Projects Agency, the US Department of Energy (DOE), and the US National Science Foundation (NSF). 
Funding Agency

Synthetic Biology Patents
A granted patent provides exclusive rights to an invention and allows the patent owner to prevent others from using the patented invention for a period (typically twenty years). The broad policy objectives of patenting are to incentivize research and development of useful and novel applications by allowing patent owners time to recoup costs and generate revenues and to encourage disclosure to facilitate technological progress. An application for a patent does not mean that the relevant patent examining authority will grant the patent. Additionally, the grant of a patent does not necessarily mean that there will be use, commercialization, or licensing of the invention. In short, patenting is not the same as innovation, as there are multiple other steps and factors involved in the commercialization of new technology. However, from a technological landscape scanning perspective, patent applications do provide useful signals. Patenting activity can indicate interest in the exploitation of a new technology, particularly from a corporate perspective (as corporation are the leading filers of patents in most countries), and can suggest fields of invention that are viewed as promising. Patents can serve as signals for venture financing and can generate markets for inventions, although they can also be deployed in strategic ways to extract economic returns.
It is in the nature of emerging technologies that relevant patents are not always easily defined, especially as standard patent classifications typically lag in being updated and also because patent applicants may use new terminology or deliberately not use specific terminologies. We have developed a method for discerning synthetic biology patents based on identifying a core set of relevant patents and keywords, then extending from this corpus to other relevant patents using a citation-tree algorithm (see section on methods and sources for added details and references). For the priority year period 2003 to August 3, 2018, from 9,263 Derwent Innovations synthetic biology patent records we matched 8,460 PATSTAT basic patent application records (for the original invention in a patent family) to obtain assignee geographical information. There are over 10,600 original patent assignees named in these records, comprised of about 3,600 original assignees standardized by name in PATSTAT. Nearly 16% of the patent records indicate more than one assignee. Some 36% of the assignees are associated with multiple patents, while some assignees are part of larger multinational corporations. The majority of patents are associated with multiple inventors (for patents where inventor names are recorded, just 5% are single inventor patents). In total, our synthetic biology patent records name about 23,000 inventors, of whom 23% are inventors who have filed more than one patent.
As in many patent landscapes searches, we acknowledge that the boundaries of the domain, in this case synthetic biology, are hard to delineate. We have pursued a broad definition of the domain (noting that few patents actually use the exact terminology "synthetic biology"). We recognize that there are inevitably trade-offs in precision and recall. At an aggregated level, however, the search approach is useful for indicating broad patenting trends.
We primarily analyze patent applications. Unless otherwise indicated, the use of the term "patent" in the text denotes a patent application. In addition to the caveats noted above (e.g. patent applications may signal interests in innovation but they are not in themselves innovations), patent applications are usually not disclosed until at least 18 months from being filed, and there are procedures that applicants can use to further extend disclosure. This means that patent application records for the most recent years are not complete. 
Growth in Synthetic Biology Patenting
Our analysis indicates upward worldwide growth in synthetic biology patent applications. Synthetic biology publications also have an upward worldwide growth (Figure 8 ). From 2007 through to 2011, there was a noticeable increase in synthetic biology patent applications. Since 2011, the growth rate of patenting tracks that of publishing, suggesting broadly comparable growth levels of global activity in knowledge exploration and invention exploitation in the synthetic biology domain. (We again note that the apparent drop-off in published patent applications from 2015-2016 to the present should not be taken as a real decline, as it reflects the gap between patent filing and publication. This gap is typically 18 months but can be longer in some circumstances.) The United States accounts for more than one-half of all synthetic biology patent applications, by location of the original patent assignee. (Figure 9 ). Assignees based in Japan account for about 9% of worldwide patents, followed by those located in Switzerland (5.5%, Germany (5%) and other European countries. Great Britain accounts for about 3% of worldwide patents. Our data does not as yet show a high level of Chinese synthetic biology patenting (there may be time lags in capturing applications from China's State Intellectual Property Office).
Figure 9. Synthetic Biology Patents, By Country
National Patenting Variations
While at an aggregated global scale, the growth of synthetic biology publications has been mirrored by comparable growth in synthetic biology patent applications, there are significant variations among the leading countries. Denmark, Switzerland and Japan have higher rates of synthetic biology patenting relative to their synthetic biology publication authorships. The USA and the Netherlands patent at rates only slighly below their level of publications. Synthetic biology patenting by assignees located in Great Britain is low (.20) relative to the high rate of synthetic biology publishing by UK researchers. 
Leading Patent Assignees
Companies are most frequent among the world's leading patent assignees in the synthetic biology domain, with 27 companies present among the top 41 assignees. This top group also contains universities and non-profit research organizations, particularly in the US and to a lesser extent in Japan, France, and Singapore. The US is the leading location for patent assignees, with 26 organizations, followed by Denmark and Japan (each with three) and France and Switzerland (two each). (Figure 11 .) The leading British patent assignee is the Glaxo Group / GlaxoSmithKline (76 th globally). There are six companies among the top (11) British patent assignees, four universities and one governmental non-profit research organization. (Figure 12 ). When reviewing these results, keep in mind our previous caveats about limitations and trade-offs in precision and recall in identifying synthetic biology patents. 
Synthetic Biology Patenting Visualized on the Map of Patents
Synthetic biology patenting covers a broad range of technological and application areas. Just over 100 International Patent Classification (IPC) subclasses (or about 16% of all IPC subclasses) are represented in our synthetic biology patent data set, with the largest patent subclasses including mutation or genetic engineering (C12N), measuring or testing processes involving enzymes, nucleic acids or microorganisms (C12Q), and medicinal preparations containing genetic material (A61K). An individual patent may be classed under multiple IPCs. To visualize the distribution of synthetic biology patents, we have mapped the worldwide synthetic biology patent set onto a base map of patents, organized into 35 major technological groups (Figure 13 ). This highlights major clusters in areas of biotechnology, drugs, instrumentation, pesticides, and catalysts, with smaller groups in food, detergents, information technology, and filtration and fibers. A mapping of patents with assignees located in Great Britain is shown, on the same base map of patents, is also shown (Figure 14) . 
